Critical Care

Medicine & Life Sciences

1. Pediatrics 100%
2. Extracorporeal Membrane Oxygenation 98%
3. Child 55%
4. Critical Illness 41%
5. Neutrophils 32%
6. Critical Care 24%
7. Traumatic Brain Injury 24%
8. Pediatric Intensive Care Units 23%
9. Brain Injuries 20%
10. Lung 19%
11. NADPH Oxidases 19%
12. Respiratory Insufficiency 18%
13. Lung Injury 18%
14. Heart Arrest 17%
15. NADPH Oxidase 2 16%
16. Mechanical Ventilators 15%
17. Cardiopulmonary Resuscitation 15%
18. Induced Hypothermia 15%
19. Mortality 14%
20. Endothelial Cells 14%
21. Guidelines 13%
22. Sepsis 13%
23. Hypoxia 13%
24. Wounds and Injuries 13%
25. Transendothelial and Transepithelial Migration 13%
26. Septic Shock 11%
27. Heart Diseases 11%
28. Brain 11%
29. Continuous Renal Replacement Therapy 10%
30. Oxygen 10%
31. Mouse Cybb protein 10%
32. Stem Cells 10%
33. Reactive Oxygen Species 10%
34. Newborn Infant 9%
35. Organizations 9%
36. Vaping 9%
37. Cardiopulmonary Bypass 9%
38. High-Frequency Ventilation 9%
39. Therapeutics 9%
40. Survival 9%
41. Randomized Controlled Trials 8%
42. Pediatric Hospitals 8%
43. Anions 8%
44. Neutrophil Infiltration 8%
45. Inflammation 8%
46. Tracheostomy 8%
47. Coronavirus 8%
48. Intensive Care Units 8%
49. Systematic Reviews 8%
50. Hypotension 8%
51. Endotoxins 8%
52. Heart Failure 7%
53. Ventilator Weaning 7%
54. Cohort Studies 7%
55. Registries 7%
56. Acute Kidney Injury 7%
57. Near-Infrared Spectroscopy 7%
58. Thoracic Surgery 7%
59. parthenolide 7%
60. Artificial Respiration 7%
61. Out-of-Hospital Cardiac Arrest 7%
62. Ventilation 6%
63. Systemic Inflammatory Response Syndrome 6%
64. Hemodynamics 6%
65. Neurogenesis 6%
66. Craniocerebral Trauma 6%
67. Insulin 6%
68. Francisella tularensis 6%
69. Acute Lung Injury 6%
70. Glucose 6%
71. Electronic Nicotine Delivery Systems 6%
72. Clinical Trials 6%
73. Resuscitation 6%
74. Population 6%
75. Hypnotics and Sedatives 5%
76. Nervous System 5%
77. Spinal Muscular Atrophy 5%
78. Child Mortality 5%
79. Lipopolysaccharides 5%
80. Psychological Adaptation 5%
81. Weaning 5%
82. Enteral Nutrition 5%
83. Retrospective Studies 5%
84. Neurofibromatosis 1 5%
85. Phenotype 5%
86. Cytokines 5%
87. Hepatocyte Growth Factor 5%
88. Dentate Gyrus 5%
89. Intracranial Pressure 5%
90. Length of Stay 5%
91. Meta-Analysis 5%
92. Coma 5%
93. Methadone 5%
94. Intubation 5%
95. Neural Stem Cells 5%
96. TOR Serine-Threonine Kinases 5%